Jury Adds $27.12 Million in Punitives to HRT Verdict

LITTLE ROCK, Ark. - A federal jury has determined that the makers of two hormone therapy replacement drugs acted with malice and reckless disregard in their failure to warn a woman that the products could cause breast cancer. Scroggin v. Wyeth, et al., No. 04-1169 (E.D. Ark.).

The finding, handed up March 6 by jurors in the U.S. District Court for the Eastern District of Arkansas, was accompanied by a more than $27 million award to plaintiff Donna Scroggin, who less than a month ago was awarded $2.75 in compensatory damages for injuries she claimed were caused by Provera and …